Adam J. Mead

机构：Churchill Hospital, National Institute for Health and Care Research, MRC Weatherall Institute of Molecular Medicine, MRC Human Immunology Unit, Oxford BioMedica (United Kingdom), Oxford University Hospitals NHS Trust · ORCID：0000-0001-8522-1002

发表论文 389 篇 · 总被引 13863 次 · h-index 58

代表论文

• Tumor-Infiltrating Clonal Hematopoiesis (2025 · New England Journal of Medicine · 被引 102)
• Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis (2024 · Blood Advances · 被引 46)
• Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells (2024 · Nature Immunology · 被引 43)
• A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis (2024 · Science Translational Medicine · 被引 41)
• Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA (2025 · Science · 被引 37)
• Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors From the UK Biobank (2024 · JACC CardioOncology · 被引 30)